Henry Schein, Inc. (HSIC)

Market Cap	9.02B
Revenue (ttm)	12.34B
Net Income (ttm)	416.00M
Shares Out	128.51M
EPS (ttm)	3.16
PE Ratio	22.22
Forward PE	13.56
Dividend	n/a
Ex-Dividend Date	n/a

Volume	993,267
Open	71.55
Previous Close	71.22
Day's Range	70.19 - 71.92
52-Week Range	60.01 - 85.39
Beta	0.86
Analysts	Buy
Price Target	81.82 (+16.55%)
Earnings Date	May 7, 2024

About HSIC

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum,...

• Industry: Medical Distribution
• Sector: Healthcare
• IPO Date: Nov 3, 1995
• Employees: 25,000
• Stock Exchange: NASDAQ
• Ticker Symbol: HSIC

Financial Performance

In 2023, Henry Schein's revenue was $12.34 billion, a decrease of -2.44% compared to the previous year's $12.65 billion. Earnings were $416.00 million, a decrease of -22.68%.

Analyst Forecast

According to 11 analysts, the average rating for HSIC stock is "Buy." The 12-month stock price forecast is $81.82, which is an increase of 16.55% from the latest price.

Price Target

$81.82

(16.55% upside)

Analyst Consensus: Buy